Cannabis Weekly Round-Up: LPs Sign Deal with New Brunswick for Recreational Cannabis
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
Your trusted source for investing success
Your trusted source for investing success
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
InMed Pharmaceuticals announced the filing of a provisional patent application pertaining to the Company’s proprietary biosynthesis program for the manufacture of cannabinoids that are identical to those found in nature.
By Shelly Kumar
Isodiol International Inc. (CSE:ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global cannabinoid innovator specializing in the development of pharmaceutical and consumer products, announces that it has initiated the process of obtaining a secondary listing on the Australian Stock Exchange (ASX) and expects this process to be completed by
By Shelly Kumar
CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed” or the “Company”) today released its financial results for the three and nine months ended July 31, 2017.
Highlights
Sales of $4.8 million in the quarter were 80 per cent higher than in the comparable period of the prior year and were 29 per cent higher than the second quarter of 2017.
Tetra Bio-Pharma incorporated Dr. Louis-Philippe de Lorimier into their clinical advisory board for the veterinary market.
By Jocelyn Aspa
The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.
Organigram Holdings announced it entered into a memorandum of understanding with the New Brunswick Innovation Research Chair in Medical Technologies in which the two will jointly develop an industry leading method of microwave extraction of cannabinoid extracts from marijuana plants.
By Shelly Kumar
President, Director, & Founder of Naturally Splendid (TSXV:NSP) Enterprises Ltd. J. Craig Goodwin, presented at the Global Chinese Financial Forum, in Shanghai.
Please use the link below to view the 30 minute presentation:
About Naturally Splendid Enterprises Ltd.
Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an
By Shelly Kumar
Isodiol International Inc. (CSE:ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabinoid innovator specializing in the development of pharmaceutical and consumer products announces that it is proud to be launching a new Phytoceutical Division that will focus on cannabinoids and terpenes derived from non-cannabis sources.
Proprietary extraction methods ensure
The Investing News reported took a closer look at some of the big cannabis news of the week and published an interview with the president of Cannabis Wheaton.
Organigram Holdings announced the addition of a pure CBD edible oil product to their lineup of offerings.
ICC International Cannabis announced its interim financial results for the second quarter of 2017.
By Shelly Kumar
Isodiol International Inc. (CSE:ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabinoid innovator specializing in the development of pharmaceutical and consumer products announces it has signed a distribution partnership with FarmaUSA™, a leading global wholesale distributor of imported pharmaceutical products in South America. This is the latest action
Aequus Pharmaceuticals announced it entered a new collaboration with Ehave.
Tetra Bio-Pharma announced a set of new appointments to prepare for the start of their commercial activities.
By Shelly Kumar
Isodiol International Inc. (CSE:ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator, specializing in the development of pharmaceutical and consumer products, announces it proudly exhibited at the US Autism & Asperger Association (USAAA) (http://usautism.org/conferences/schedule.html) conference this past weekend in Portland, Oregon and sponsored Dr. Ronald Aung-Din to educate
By Shelly Kumar
Naturally Splendid (TSXV:NSP) is pleased to announce its financial results for the second quarter ended June 30th , 2017. All amounts are in Canadian dollars and are prepared in accordance with International Financial Reporting Standards.
Naturally Splendid recorded sales of $481,746 and $1,068,949 during the three and six months ended June 30, 2017, compared to
By Shelly Kumar
RespireRx Pharmaceuticals Inc. (OTCQB:RSPI) (“RespireRx” or the “Company”), a leader in the development of medicines for the treatment of neurologically controlled respiratory disorders, including obstructive sleep apnea and opioid induced respiratory depression (a form of central apnea) and other respiratory and neurological conditions, has filed its June 30, 2017 Quarterly Report
Maricann Group has further solidified its stance into the biotech business of cannabis by completing the acquisition of NanoLeaf Technologies.
By Shelly Kumar
Naturally Splendid (TSXV:NSP) is pleased to announce that it has closed the initial tranche of its previously announced private placement financing by issuing a total of 3,643,277 units (the “Units”) for gross proceeds of $655,789.
Each Unit is comprised of one common share of Naturally Splendid and one-half of one common share purchase warrant (“Warrant”), with
